Abstract: 
 Background: Postpartum Hemorrhage (PPH) is the most common reason of maternal death globally. Misoprostol and oxytocin are two first line effective management protocols. But controversies exist in literature. For that matter, this study was conducted.
 Objectives: To compare frequency postpartum hemorrhage with per rectal misoprostol relation to intramuscular females under...

Background and objective: The objective of this work is to match the security effectiveness two treatment modalities (Misoprostol versus Letrozol with Misoprostol) in medical 1st trimesteric missed miscarriages. Methods: This an interventional randomized case-control investigation that was performed at outpatient antenatal care clinic Luxor General Hospital during period from February December ...

Postpartum hemorrhage is an important cause of maternal morbidity and mortality after delivery. Active management of postpartum hemorrhage by an uterotonic drug decreases the rate of postpartum hemorrhage. The aim of this study is to evaluate the efficacy of rectal misoprostol for prevention of postpartum hemorrhage. This double blind randomized clinical trial was performed on full term pregnan...

BACKGROUND The effect of a novel slow release form of misoprostol (SR misoprostol) on uterine activity during early pregnancy was investigated in a pilot study. METHODS Thirty women with a pregnancy between 8 and 12 weeks requesting surgical abortion were allocated to treatment according to computerized randomization. SR misoprostol (400 and 800 microg) was compared to 400 microg of conventio...

A prospective randomized, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Author: Dr Roopa Malik, Assistant Professor, Obstetrics and gynaecology department Pt BDS PGIMS Rohtak. Background: Vaginal misoprostol has been shown to be an effective single agent for medical agent for medical abortion. Th...